Literature DB >> 20529617

2006 Curt Stern Award Address. Marfan syndrome: from molecules to medicines.

Harry C Dietz1.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 20529617      PMCID： PMC2227916          DOI： 10.1086/521409

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  34 in total

1.  Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome.

Authors:  D W Hollister; M Godfrey; L Y Sakai; R E Pyeritz
Journal:  N Engl J Med       Date:  1990-07-19       Impact factor: 91.245

2.  Role of the latent transforming growth factor beta binding protein 1 in fibrillin-containing microfibrils in bone cells in vitro and in vivo.

Authors:  S L Dallas; D R Keene; S P Bruder; J Saharinen; L Y Sakai; G R Mundy; L F Bonewald
Journal:  J Bone Miner Res       Date:  2000-01       Impact factor: 6.741

3.  Location on chromosome 15 of the gene defect causing Marfan syndrome.

Authors:  K Kainulainen; L Pulkkinen; A Savolainen; I Kaitila; L Peltonen
Journal:  N Engl J Med       Date:  1990-10-04       Impact factor: 91.245

4.  Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome.

Authors:  T E Bunton; N J Biery; L Myers; B Gayraud; F Ramirez; H C Dietz
Journal:  Circ Res       Date:  2001-01-19       Impact factor: 17.367

5.  Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice.

Authors:  Christopher P Denton; Bing Zheng; Lowri A Evans; Xu Shi-wen; Voon H Ong; Ivan Fisher; Konstantinos Lazaridis; David J Abraham; Carol M Black; Benoit de Crombrugghe
Journal:  J Biol Chem       Date:  2003-04-21       Impact factor: 5.157

6.  Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein.

Authors:  Zenzo Isogai; Robert N Ono; Shin Ushiro; Douglas R Keene; Yan Chen; Roberta Mazzieri; Noe L Charbonneau; Dieter P Reinhardt; Daniel B Rifkin; Lynn Y Sakai
Journal:  J Biol Chem       Date:  2002-11-11       Impact factor: 5.157

7.  Angiotensin II type 1 receptor antagonist (losartan) down-regulates transforming growth factor-beta in experimental acute pyelonephritis.

Authors:  A Khalil; K Tullus; M Bakhiet; L G Burman; G Jaremko; A Brauner
Journal:  J Urol       Date:  2000-07       Impact factor: 7.450

8.  Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome.

Authors:  Enid R Neptune; Pamela A Frischmeyer; Dan E Arking; Loretha Myers; Tracie E Bunton; Barbara Gayraud; Francesco Ramirez; Lynn Y Sakai; Harry C Dietz
Journal:  Nat Genet       Date:  2003-02-24       Impact factor: 38.330

9.  Heterozygous TGFBR2 mutations in Marfan syndrome.

Authors:  Takeshi Mizuguchi; Gwenaëlle Collod-Beroud; Takushi Akiyama; Marianne Abifadel; Naoki Harada; Takayuki Morisaki; Delphine Allard; Mathilde Varret; Mireille Claustres; Hiroko Morisaki; Makoto Ihara; Akira Kinoshita; Koh-ichiro Yoshiura; Claudine Junien; Tadashi Kajii; Guillaume Jondeau; Tohru Ohta; Tatsuya Kishino; Yoichi Furukawa; Yusuke Nakamura; Norio Niikawa; Catherine Boileau; Naomichi Matsumoto
Journal:  Nat Genet       Date:  2004-07-04       Impact factor: 38.330

10.  Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1.

Authors:  Takayuki Naito; Takao Masaki; David J Nikolic-Paterson; Chie Tanji; Noriaki Yorioka; Nobuoki Kohno
Journal:  Am J Physiol Renal Physiol       Date:  2003-10-28
View more
  5 in total

1.  Coding Microsatellite Frameshift Mutations Accumulate in Atherosclerotic Carotid Artery Lesions: Evaluation of 26 Cases and Literature Review.

Authors:  Carolin Kurz; Maani Hakimi; Matthias Kloor; Caspar Grond-Ginsbach; Marie-Luise Gross-Weissmann; Dittmar Böckler; Magnus von Knebel Doeberitz; Susanne Dihlmann
Journal:  Mol Med       Date:  2015-06-09       Impact factor: 6.354

Review 2.  Vascular smooth muscle cells in Marfan syndrome aneurysm: the broken bricks in the aortic wall.

Authors:  Gianluca L Perrucci; Erica Rurali; Aoife Gowran; Alessandro Pini; Carlo Antona; Roberto Chiesa; Giulio Pompilio; Patrizia Nigro
Journal:  Cell Mol Life Sci       Date:  2016-08-17       Impact factor: 9.261

3.  Exome Sequencing Identifies Genetic Variants Associated with Extreme Manifestations of the Cardiovascular Phenotype in Marfan Syndrome.

Authors:  Yanireth Jimenez; Cesar Paulsen; Eduardo Turner; Sebastian Iturra; Oscar Cuevas; Guillermo Lay-Son; Gabriela M Repetto; Marcelo Rojas; Juan F Calderon
Journal:  Genes (Basel)       Date:  2022-06-08       Impact factor: 4.141

4.  Expressions of Transforming Growth Factor β1 Signaling Cytokines in Aortic Dissection.

Authors:  Shi-Min Yuan; Hong Lin
Journal:  Braz J Cardiovasc Surg       Date:  2018 Nov-Dec

5.  Treatment With Methotrexate Associated With Lipid Core Nanoparticles Prevents Aortic Dilation in a Murine Model of Marfan Syndrome.

Authors:  Maria Carolina Guido; Natalia de Menezes Lopes; Camila Inagaki Albuquerque; Elaine Rufo Tavares; Leonardo Jensen; Priscila de Oliveira Carvalho; Thauany Martins Tavoni; Ricardo Ribeiro Dias; Lygia da Veiga Pereira; Francisco Rafael Martins Laurindo; Raul Cavalcante Maranhão
Journal:  Front Cardiovasc Med       Date:  2022-06-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.